{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:51:11Z","timestamp":1793731871728,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.eururo.2011.07.002","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T14:36:57Z","timestamp":1311259017000},"page":"742-750","source":"Crossref","is-referenced-by-count":417,"title":["Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"60","author":[{"given":"Francisco","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sender","family":"Herschorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Aliotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Brin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Daniell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Heesakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Haag-Molkenteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2011.07.002_bib0005","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1046\/j.1464-410X.1997.00191.x","article-title":"Vesico-ureteric reflux in adult patients with spinal injury","volume":"79","author":"Foley","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00002060-200112000-00008","article-title":"Bladder management and quality of life after spinal cord injury","volume":"80","author":"Hicken","year":"2001","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.eururo.2011.07.002_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ucl.2010.06.004","article-title":"Pharmacologic therapy for the neurogenic bladder","volume":"37","author":"Cameron","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.eururo.2011.07.002_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-410X.2006.06258.x","article-title":"Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?","volume":"98","author":"Finney","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.07.002_bib0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sc.1996.51","article-title":"Intravesical oxybutynin for spinal cord injury patients","volume":"34","author":"Szollar","year":"1996","journal-title":"Spinal Cord"},{"key":"10.1016\/j.eururo.2011.07.002_bib0035","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.juro.2010.12.002","article-title":"Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-a for detrusor overactivity in patients with multiple sclerosis","volume":"185","author":"Khan","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox\u00ae) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0050","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.eururo.2011.07.002_bib0055","series-title":"Therapy with botulinum toxin","first-page":"93","article-title":"Immunogenicity of the neurotoxins of Clostridium botulinum","author":"Hatheway","year":"1994"},{"key":"10.1016\/j.eururo.2011.07.002_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","article-title":"EAU guidelines on neurogenic lower urinary tract dysfunction","volume":"56","author":"Stohrer","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-5347(17)54449-3","article-title":"Prognostic value of urodynamic testing in myelodysplastic patients","volume":"126","author":"McGuire","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00345-006-0087-x","article-title":"Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management","volume":"24","author":"Bruschini","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.2011.554399","article-title":"The medical treatment of overactive bladder, including current and future treatments","volume":"12","author":"Athanasopoulos","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eururo.2011.07.002_bib0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","article-title":"Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review","volume":"326","author":"Herbison","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2011.07.002_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.apmr.2007.02.009","article-title":"Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence","volume":"88","author":"Schurch","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.eururo.2011.07.002_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00345-009-0466-1","article-title":"Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany","volume":"28","author":"Wefer","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0095","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0100","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0105","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/AOG.0b013e3181a1f5ea","article-title":"Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life","volume":"113","author":"Kessler","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0022-5347(17)36136-0","article-title":"Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization","volume":"149","author":"Bakke","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.002_bib0115","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0924-8579(02)00114-0","article-title":"Urinary tract infection in patients with neurogenic bladder dysfunction","volume":"19","author":"Sauerwein","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eururo.2011.07.002_bib0120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0733-8619(18)30277-9","article-title":"Neurogenic urinary tract infection","volume":"9","author":"Stover","year":"1991","journal-title":"Neurol Clin"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811007391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811007391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T01:31:36Z","timestamp":1560389496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283811007391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0302283811007391"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2011.07.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13393973.14762081","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}